Saltoro Capital LP trimmed its holdings in Insmed Incorporated (NASDAQ:INSM – Get Rating) by 99.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,400 shares of the biopharmaceutical company’s stock after selling 2,994,600 shares during the quarter. Insmed accounts for approximately 0.1% […]